16.07.2026
Sun Pharma’s Generic Semaglutide is now available in South Africa. Explore this new treatment option for type 2 diabetes.
30.10.2024
Aspen Pharmacare has secured a licensing agreement to enter the GLP-1 agonist market, positioning it for growth in diabetes and obesity treatment solutions.
24.10.2024
Novo Nordisk's share price dropped 19% amidst growing competition from Eli Lilly in the diabetes and weight-loss drug market.